Patent details

Basic Information

Publication number:

EP3555128

PCT Application Number:

IL2017051351

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP178819306

PCT Publication Number:

WO2018109770

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTI-PCNA MONOCLONAL ANTIBODIES AND USE THEREOF

French Title of Invention:

ANTICORPS MONOCLONAUX ANTI-PCNA ET LEUR UTILISATION

German Title of Invention:

MONOKLONALE ANTI-PCNA-ANTIKÖRPER UND VERWENDUNG DAVON

SPC Number:

Dates

Filing date:

14/12/2017

Grant date:

27/12/2023

EP Publication Date:

23/10/2019

PCT Publication Date:

21/06/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/12/2023

EP B1 Publication Date:

27/12/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

14/12/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/12/2023

 

 

Name:

The National Institute for Biotechnology in the Negev Ltd.

Address:

Building 39, Ben Gurion University of the Negev,, 84105 Beer-Sheva, Israel (IL)

Inventor

Name:

PORGADOR, Ari-Angel

Address:

Israel (IL)

Priority

Priority Number:

201662434532 P

Priority Date:

15/12/2016

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/18; A61K 39/395;

Publication

European Patent Bulletin

Issue number:

202352

Publication date:

27/12/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

30/06/2025

Annual Fee Number:

8

Annual Fee Amount:

99 Euro

Penalty Fee Amount:

20 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages